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Abstract
Integration of the double-stranded DNA copy of the HIV-1 genome into host chromosomal DNA is a requirement for
efficient viral replication. Integration preferentially occurs within active transcription units, however chromosomal site
specificity does not correlate with any strong primary sequence. To investigate whether the nuclear architecture may affect
viral integration we have developed an experimental system where HIV-1 viral particles can be visualized within the nuclear
compartment. Fluorescently labeled HIV-1 virions were engineered by fusing integrase, the viral protein that catalyzes the
integration reaction, to fluorescent proteins. Viral tests demonstrate that the infectivity of fluorescent virions, including the
integration step, is not altered as compared to wild-type virus. 3-D confocal microscopy allowed a detailed analysis of the
spatial and temporal distribution of the pre-integration complexes (PICs) within the nucleus at different moments following
infection; the fluorescently labeled PICs preferentially distribute in decondensed areas of the chromatin with a striking
positioning in the nuclear periphery, while heterochromatin regions are largely disfavored. These observations provide a
first indication of how the nuclear architecture may initially orient the selection of retroviral integration sites.
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Introduction
HIV-1 to efficiently complete a replication cycle has to integrate
its genome into the host cellular DNA. This reaction is catalyzed
by the virus-encoded protein integrase (IN). IN together with other
viral and cellular proteins forms the pre-integration complex (PIC)
and binds specific sequences located at the ends of the viral cDNA
(att sites) [1]. So far no primary sequence in the cellular genome
has been identified as the preferential binding site for IN during
viral integration, though a weakly conserved palindromic sequence
has been identified [2–5]. Notwithstanding the lack of strong
sequence specificity, recent evidence suggests that retroviral
integration does not occur at random in DNA molecules. Indeed,
it has been demonstrated that the majority of retroviruses
preferentially integrates in DNase I hypersensitive regions [6–10]
and in transcriptionally-active chromosomal regions [11–16].
Symmetrically, other authors showed that centromeric alphoid-
repeat regions are disfavored integration sites [2]. Noteworthy,
DNase hypersensitive regions and transcriptionally active genes
are found in open-decondensed chromatin regions, in contrast
with alpha repeats which are known to localize in closed-
condensed chromatin regions. These observations together with
in vitro data [17] suggest that chromatin structure may represent a
determinant factor for target-site selection during retroviral
integration. In eukaryotic cells DNA is assembled with nucleo-
somes to form chromatin, which assumes at least two distinct
structural and functional forms: a condensed form that generally
lacks DNA regulatory activity and a looser, decondensed form that
provides the environment for DNA regulatory processes such as
DNA replication, repairs and transcription. Chromatin is
compartmentalized within the nucleus under a specific nuclear
architecture.
HIV-1 replication has been extensively studied using a wide
array of molecular biology, biochemistry and structural biology
approaches. However, in order to verify a role of the chromatin
structure and distribution during the viral life cycle is critical to
directly visualize the virus inside intact nuclei of infected cells.
Therefore, we have developed an experimental system that, by
exploiting the power of three-dimensional optical dissection of sub-
cellular structures, would be potentially able to simultaneously
visualize HIV-1 particles and chromatin organization within intact
nuclei.
To this aim, we have engineered viral particles containing IN
fused to the Enhanced Cyan/Green Fluorescent Protein (IN-
ECFP/IN-EGFP) through the ‘‘trans-incorporation’’ technique.
This method exploits the Vpr property to shuttle fused exogenous
proteins inside the viral particles [18]. This approach was
successfully used to produce HIV-1 infectious particles containing
a functional IN fused to LexA [19]. We demonstrate that the IN-
EGFP containing virions are infectious and can be visualized
within the nuclear compartment. To establish the intranuclear
localization of the fluorescent viral particles, we have exploited at
least two methods for nuclear visualization: nuclear lamina
immunostaining and expression of histones H2B fused to the
Enhanced Yellow Fluorescent Protein (H2B-EYFP). This system
has proven valid to analyze virus-nuclear structure interaction and
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distributed at the nuclear level with respect to chromatin structure
and nuclear architecture.
Results
Construction of HIV-1 containing IN-EGFP fusion proteins
The introduction of exogenous coding sequences into the
provirus impairs the genome processing and consequently the
synthesis of viral particles. Therefore, to incorporate IN fused to
the chosen fluorophore (ECFP or EGFP) in HIV-1 virions we
exploited the Vpr-trans method [18]. Vpr is incorporated into viral
particles through its interaction with p6 of Gag; thus by fusing a
non-viral protein to the C-terminus of Vpr the exogenous factor is
shuttled inside the virions. As previously described [18] a HIV-1
sensitive proteolytic site has been introduced between Vpr and IN
allowing the separation of the IN-EGFP fusion protein to catalyze
the integration reaction. Pseudotyped HIV-1 viral stocks contain-
ing IN-EGFP (HIV-IN-EGFP) were prepared by expressing in
293T cells the Vpr-IN-EGFP fusion protein, the VSV-G envelope
protein and the proviral construct pD64E. This HIV-1 clone is
derived from an env-deleted pNL4.3 provirus expressing the
luciferase reporter gene and a mutated IN protein. Since the
substitution from Asp 64 to Glu suppresses IN catalytic activity,
the IN-EGFP fusion protein provided in trans exclusively mediates
the integration of the recombinant HIV-1 fluorescent virions.
In order to determine whether the IN-EGFP fusion protein is
efficiently incorporated into viral particles, concentrated viruses
were analyzed by western blot. Using specific anti-IN antibodies, a
band of the same size of IN (32 kDa) is detected in HIV-IN-EGFP
virus as well as in control NL4-3.Luc.R-E- (wild-type), and D64E
(mutated) viruses (Fig. 1A, left panel). In addition, two bands
corresponding respectively to Vpr-IN-EGFP and to its proteolytic
product IN-EGFP are exclusively visible in the fluorescently
Figure 1. IN-EGFP trans-incorporation through Vpr produces intact and infective viral particles. (A) IN-EGFP is incorporated into intact
HIV-1 virions. Supernatant from un-transfected control cells (lane 1) or cells transfected with pVSV-G and pNL4-3.Luc.R-E- (lane 2), pD64E (lane 3) or
pD64E together with pVpr-IN-EGFP (lane 4) were pelleted by ultra-centrifugation through a 20% sucrose cushion and analyzed by western blot using
antibodies anti-IN (left panel) or with an anti-HIV-1 human serum (right panel). (B) HIV-IN-EGFP virions are infective. Ultracentrifuged supernatants
from cells producing the indicated viruses were normalized for p24 content and used to infect HeLa cells. Seven days post-infection cell lysates were
analyzed for luciferase activity. Luciferase activity values were normalized for protein content of lysates and expressed as relative light units (RLU). (C)
HIV-IN-EGFP virions integrate in the cellular genome. DNA extracted from HeLa cells infected for 24 hours with a NL4-3.Luc.R-E- (lane 1), D64E (lane 2)
or HIV-IN-EGFP (lane 3) viruses pseudotyped with VSV-G were amplified with primers specific for the Alu-LTR (to analyze the fraction of integrated
HIV-1 DNA-upper panel) and for the lamin B2 cellular gene (to standardize the total amount of extracted DNA- lower panel).
doi:10.1371/journal.pone.0002413.g001
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incorporated and is subsequently digested by the viral protease.
Moreover, protein synthesis and maturation is not affected by
Vpr-IN-EGFP trans incorporation, as indicated by an unmodified
pattern of viral proteins visualized by an HIV-1 antiserum (Fig. 1A,
right panel). The infectivity of IN-EGFP containing virions was
then tested by measuring luciferase activity 7 days after infection.
As expected, infection with the D64E virus produces very low
levels of luciferase as compared to wild-type NL4-3.Luc.R-E-
(Fig. 1B). Conversely, infection with the HIV-IN-EGFP virus
showed luciferase activity at a level comparable to the wild type.
This clearly demonstrates that IN-EGFP can efficiently trans
complement the catalytically inactive IN expressed by the D64E
provirus. Finally, in order to prove that the infectivity of
recombinant fluorescent virions occurs through reconstituted
integration capacity, quantification of integrated proviral DNA
was assessed by Alu-PCR. As expected, integrated viral DNA was
observed in cells infected with the NL4-3.Luc.R-E- and not with
the D64E virus (Fig. 1C, upper panel, lanes 1 and 2); cells infected
with the HIV-IN-EGFP virus (lane 3) showed levels of proviral
DNA similar to wild-type, demonstrating that the trans incorpo-
ration of IN-EGFP protein has successfully recovers the integra-
tion process.
Visualization of HIV-1 virions containing IN-EGFP
The supernatant from 293T cells producing the HIV-IN-EGFP
virus was concentrated by ultra-centrifugation and bound to glass
coverslips. IN-EGFP containing viral particles were readily
visualized and, consistently with former reports, they appeared
heterogeneous in size and with a broad distribution of fluorescence
intensity [20] (Fig. 2, upper right panel). To prove that the
visualized fluorescent dots are indeed viral particles, the same viral
supernatant was immunostained with antibodies recognizing the
viral proteins matrix (p17
MA) and capsid (p24
CA) (Fig. 2, central-
and bottom- right panels respectively). The merged image in Fig. 2,
left panel, shows overlapping fluorescence signals (white dots)
indicating that the majority of IN-EGFP virions are also positive
for viral proteins. This analysis was also carried out in HeLa cells
infected with viral supernatants. Point sources of EGFP fluores-
cence could be detected in the cells presumably marking the
presence of viral PICs containing IN-EGFP. In order to verify the
actual viral nature of the EGFP signals, cells were stained with
antibodies against p17
MA and p24
CA. Figure 3A shows that the
majority of EGFP spots were positive for p17
MA and, consistently
with Mc Donald et al. [21], colocalization was also observed with
p24
CA (Fig. 3B).
Functionally active PICs should associate with newly synthe-
sized cDNA produced by reverse transcriptase (RT) activity. In
order to verify whether the observed HIV-IN-EGFP PICs contains
an intact RT, the natural endogenous reverse transcription
(NERT) activity associated to extracellular virions was assessed
by labeling and then visualizing the neo-synthesized cDNA. It was
demonstrated that the NERT activity determines partial polymer-
ization of the negative strand cDNA of infectious virions [22] and
that this polymerization can be further activated by the addition of
dNTPs [23,24]. We incubated the HIV-IN-EGFP viral superna-
tant in the presence of fluorescently labeled deoxynucleotides
(Alexa-594-dUTP) using appropriate conditions for viral RT
activity. Following infection, EGFP labeled PICs were indeed
found associated with fluorescently labeled cDNA (Fig. 4)
demonstrating that IN-EGFP PICs contains a functionally active
RT. Figure 4 shows, however, that only a minority of IN-EGFP
spots overlap with fluorescently labeled cDNA. This reduced
number of positive PICs can be explained by the rather low
efficiency of the NERT assay and to the reported observation that
only a limited number of entered viral particles is actually infective
[25].
Nuclear visualization of HIV-IN-EGFP PICs
IN is part of the viral PIC from the early steps of infection up to
the integration event in the cellular genome. Thus, PICs
containing IN fused to a fluorescent protein should be visible
both in the cytoplasm and in the nuclear compartment. In order to
specifically examine HIV-IN-EGFP PICs within the nuclear
compartment, the nucleus of infected cells was visualized by
immunostaining with antibodies recognizing the nuclear lamina
(lamin A/C), which clearly defines the nucleus-cytoplasm
boundary. Indeed, due to the irregularity of the nuclear
membrane - determined by protrusions extending both inside
and outside the nuclear surface – exact information on the 3D
nuclear envelope shape are necessary to prove the nuclear
localization of the observed PICs. In particular, it is necessary to
define a spatial separation between the fluorescence sources of the
signal deriving from the nuclear membrane and the one
originating from the viral PICs. To this aim distorsions introduced
by the microscope are removed by deconvolving z stacks
containing IN-ECFP or IN-EGFP and lamin A/C Alexa-680
signals using experimentally determined point spread function
(PSF) (see Methods).
The real nuclear envelope profile (blue) and PICs (green)
positions are thus assessed as illustrated in Fig. 5; panel A
illustrates a single x-y section showing three distinct intranuclear
PICs while panel B reports adjacent vertical nuclear sections
derived from the same dataset. The three identified PICs (white
labeled ‘‘1’’, ‘‘2’’ and ‘‘3’’) clearly localize in the inner part of the
nucleus under study and are usually visible in two adjacent frames
in line with the expected x-y resolution. This type of analysis allows
excluding PICs localized in the outer proximity or juxtaposed to
the nuclear membrane that could be mistakenly detected as
intranuclear (see Supporting Information, Fig. S1).
Figure 2. Visualization of HIV-IN-EGFP virions. Supernatants from
cells transfected with the pD64E, pVpr-IN-EGFP and pVSV-G plasmids
were ultra-centrifuged through a 20% sucrose cushion and adhered to
glass coverslips. Following rinsing and fixation, immunostaining was
performed with specific antibodies against viral proteins p17
MA and
p24
CA and then visualized for EGFP fluorescence (green), p17
MA (blue)
and p24
CA (red). Left panel is the merged image where white spots
result from overlapping green, blue and red signals. Right panels show
the individual fluorescent images. Bars, 5 mm.
doi:10.1371/journal.pone.0002413.g002
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level, HeLa cells were infected with HIV-IN-EGFP viral stocks
labeled with Alexa-594-dUTP by NERT as above described.
Figure 6A shows the colocalization in the nucleus of IN-EGFP
labeled PICs with neo-synthesized cDNA, proving that the
fluorescent recombinant virus is indeed structurally intact at the
nuclear level. Also, since virions translocate into the nucleus
following p24
CA disassembly, the colocalization of p24
CA with
nuclear HIV-IN-EGFP virions was analyzed. As shown in Fig. 6B
the vast majority of PICs in the cytoplasm were positive for p24
CA,
while no PICs were stained for p24
CA in the nucleus, further
proving the functional integrity of the nuclear HIV-IN-EGFP
virions.
It was estimated that proviral DNA is detectable almost 8 hours
after HIV-1 entry [26]. We have thus quantified the number of viral
PICs at different time points from 3 to 24 hours after infection.
Figure 6C shows that the maximum number of intranuclear HIV-
IN-EGFP PICs (3.461.1; mean6SD; 30 cells) was observed after
6 hours. At subsequent times the number of PICs declined and
virtually none was detected 24 hours after infection. Finally,
compared to the total average amount of PICs per cell
(167.5633.4; mean6SD; 30 cells), at 6 hours post infection, only
a small fraction (2.060.8%) was found in the nucleus.
Distribution of HIV-1 particles in the nuclei of infected
cells
Chromatin assumes mainly two distinct conformations: con-
densed (heterochromatin) and decondensed (euchromatin). These
configurations can be visualized in HeLa cells stably expressing
histones H2B fused to EYFP (HeLa-H2B-EYFP) [27], where
higher and lower EYFP fluorescence intensity areas indicate more
and less condensed chromatin regions, respectively [28–30]. We
exploited this experimental system to study HIV-1 compartmen-
talization with respect to chromatin structure. To this end HeLa-
H2B-EYFP cells were infected with HIV-IN-ECFP, which was
used in place of EGFP to allow better spectral separation.
Additionally, to ensure a proper detection of viral PICs within the
nucleus, cells were immunostained with the nuclear lamin A/C.
Cells were then analyzed by confocal microscopy as described
above, by recording the three spectral channels corresponding to
IN-ECFP, H2B-EYFP and lamin A/C staining (Alexa-680).
Figure 7A shows four representative HeLa-H2B-EYFP (red) nuclei
delimited by the lamin A/C immunostaining (blue) and containing
individual HIV-IN-ECFP viral PICs (green). The observed
heterogeneity of the H2B-EYFP fluorescence signal (red) was
correlated with PICs localization. A total of 103 PICs were
identified in the nuclei of 70 randomly chosen cells and a region of
interest (ROI) was defined around each PIC (PIC ROIs). In
addition, the same number of ROIs was randomly chosen
within the same nuclear planes (Random ROIs). Subsequently,
Figure 3. HIV-IN-EGFP virions can be visualized in infected cells. (A) Confocal visualization of HeLa cells infected with concentrated
supernatants derived from cells transfected with the pD64E, pVpr-IN-EGFP and pVSV-G plasmids. Six hours post-infection cells were immunostained
with antibodies against p17
MA and visualized for EGFP fluorescence (green) or p17
MA staining (red). In the merged image, where cell and nuclear
shapes are outlined in white, yellow spots indicate full overlapping of green and red signals. Bar, 5 mm. Enlargements of the boxed region show
individual color and merged images. Bar, 2 mm. (B) Same as in (A) using antibodies against p24
CA.
doi:10.1371/journal.pone.0002413.g003
Figure 4. HIV-IN-EGFP virions containing neo-synthesized viral
c-DNA can be visualized in infected cells. Confocal visualization of
a HeLa cell at 6 hours after infection with HIV-IN-EGFP (green) viral
supernatant incubated with deoxynucleotides Alexa-594-dUTP (red).
The large panel shows the merged image where yellow indicates
overlapping of green and red signals. Cell and nuclear shapes are
outlined in white. Bar, 5 mm. Individual color and merged magnification
images of the boxed region are shown in the right panels. Bar, 0.5 mm.
doi:10.1371/journal.pone.0002413.g004
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immunostained with lamin A/C (blue). Acquisition of confocal images was performed as z stack with a z step size of 0.3 mm and was followed by
deconvolution based on experimentally determined PSF (see Experimental Procedure). (A) x-y section taken approximately at half high of the
analyzed nucleus. (B) Adjacent vertical projections taken every 0.301 mm from upper (top-left panel) to lower side (bottom-right panel) of the nucleus
in (A). Bars, 5 mm.
doi:10.1371/journal.pone.0002413.g005
Figure 6. Nuclear HIV-IN-EGFP virions are functionally intact. (A) Merged image of a confocal section obtained from HeLa cells infected with
HIV-IN-EGFP supernatants incubated with deoxynucleotides Alexa-594-dUTP. Yellow indicates full overlapping of EGFP and Alexa-594-dUTP signals.
Cell and nuclear shapes are outlined in white. Bars, 5 mm and 1 mm in the whole frame and inset box, respectively. (B) Merged image of a confocal
section obtained from HeLa cells infected with HIV-IN-EGFP supernatants (green) and immunostained with antibodies anti-p24
CA (red) and lamin A/C
(blue). Yellow indicates full overlapping of EGFP and anti-p24
CA signals. Cell and nuclear shapes are outlined in white. Enlargements of frames 1 and 2
are shown in bottom panels along with the individual color images. Bars, 5 mM and 1 mm in the whole frame and enlarged boxes, respectively. (C)
HeLa cells infected with HIV-IN-EGFP virions were fixed and the mean number of intranuclear viral particles per nucleus was quantified at 3 hrs, 6 hrs,
9 hrs, 12 hrs, 16 hrs and 24 hrs. At each time point an average of 30 cells was analyzed and SD represented as error bars.
doi:10.1371/journal.pone.0002413.g006
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(Fig. 7B, red bars) and compared to the H2B-EYFP fluorescence
intensity in the Random ROIs (Fig. 7B, grey bars). To obtain
comparable values among different cells, the H2B-EYFP fluores-
cence intensity was rescaled over the entire 8-bit range (0–255 a.u.)
as described in Methods. As a result of this analysis the average
H2B-EYFP fluorescence intensity was equal to 104.5611
(mean6SD) and 132.6615 (mean6SD) for PIC ROIs and
Random ROIs, respectively. The two distributions were then
compared using the non-parametric two-tailed Kolmogorov-
Smirnov test yielding a statistically significant difference
(P,0.001). These results demonstrate that PICs are non-randomly
distributed in the nuclei, showing a preferential localization in low
H2B-EYFP fluorescence intensity areas, hence in less condensed
chromatin structures.
In order to better characterize the chromatin regions occupied
by the HIV-IN-ECFP virions, the H2B-EYFP fluorescence
intensity was cross analyzed by immunofluorescence with
antibodies specific for the tri-methylated K9 of histone H3, a
post-translational modification identifying the transcriptionally
silenced heterochromatin [31]. This analysis revealed that the
average H2B-EYFP fluorescence intensity of the overlapping
regions is equal to 195 a.u. and its distribution width at half-height
ranges from 140 to 230 as indicated by the arrow in Fig. 7B.
Therefore, these data demonstrate that the high-intensity H2B-
EYFP fluorescence regions, avoided by viral PICs, are indeed
occupied by silenced heterochromatin. Interestingly, a preferential
distribution of intranuclear viral PICs was observed toward the
periphery of the nuclei. In fact, by measuring the PICs distances
from the nuclear lamina, we observed that the majority of IN-
EGFP virions localize at distances ranging from 0.4 to 2 mm from
the nuclear border, while the frequency of HIV-IN-EGFP PICs
decreases dramatically toward the center of the nuclei (Fig. 7C).
Taken together, these results indicate that viral PICs (i) are
decisively excluded from heterochromatin regions, and (ii)
frequently localize in the less condensed chromatin regions placed
in proximity to the inner nuclear envelope.
Discussion
Integration of the viral cDNA into the host cellular genome is a
necessary and intensively investigated event in retroviral replica-
tion, particularly as concerns the identification of the preferred
integration sites. To date, however, no specific genomic sequences
have been associated to such sites. Yet, unraveling the mechanisms
of integration-site selection for HIV-1 is important not only to
better understand the biology of retroviruses but also because of its
impact on other fields as retrovirus-based technology. For
instance, retroviral vectors have been extensively developed for
gene therapy applications, however their use is limited by the
uncontrollable integration site, a situation that may eventually
cause disruption of normal cellular proliferation [32]. In recent
years wide genome and transcriptome surveys revealed that
retroviral integration is favored near transcriptionally active genes
[11–16]. Mounting evidence suggest that the cellular lens
epithelium-derived growth factor (LEDGF/p75), a IN-interacting
factor [33], may direct viral integration into transcription units
[34,35]. It has been speculated that LEDGF/p75 may tether PICs
at specific sites by interacting through its PWWP domain with
specific histone modifications associated with transcriptional
elongation. Indeed, the role of the chromatin structure and of
higher order nuclear organization in retroviral integration has not
been yet investigated.
In this study we observed that chromatin structure is clearly a
determinant element for PICs distribution. Indeed, by using
HeLa-H2B-EYFP cells as an experimental system to distinguish
different chromatin structure regions, this study demonstrates that
the vast majority of PICs localize in decondensed regions of the
chromatin, as compared to more condensed areas. To better
correlate chromatin condensation forms observed in these
cells with functionally distinct regions of euchromatin or
Figure 7. HIV-IN-ECFP virions preferentially localize in the
periphery of the nucleus and outside heterochromatin regions.
(A) Confocal images of HIV-IN-ECFP virions (green) in nuclei of HeLa
cells expressing H2B-EYFP (red) and immunostained with antibody
against lamin A/C (blue). Bar, 5 mm. (B) H2B-EYFP fluorescence intensity
distribution frequency for PIC ROIs (defined by the HIV-IN-ECFP virions,
red bars) and for Random ROIs (selected randomly in the same planes,
grey bars) (n=103). Solid lines are obtained by Gaussian fitting. The
3MeK9H3 labeled arrow represents the width at half-height of the H2B-
EYFP fluorescence intensity distribution derived by cross analyzing with
this heterochromatin marker (see Experimental Procedures). In the inset
the distribution cumulative probabilities are plotted for PIC ROIs (red)
and Random ROIs (grey) (P,0.001, Kolmogorov–Smirnov test). (C)
Distribution of intranuclear PICs distances from the lamin A/C staining.
doi:10.1371/journal.pone.0002413.g007
HIV-1 Nuclear Distribution
PLoS ONE | www.plosone.org 6 June 2008 | Volume 3 | Issue 6 | e2413heterochromatin, we exploited antibodies against post-translation-
al modification of histone H3 (K9 tri-methylated) specific for
transcriptionally silenced regions of the heterochromatin [31]. Our
data clearly show that PICs are excluded from transcriptionally
silenced heterochromatin. Localization in euchromatin regions is
in accordance with a recent report showing that proviral
integration sites are characterized by specific epigenetic codes
[36]. The association with definite regions of the chromatin
marked by specific post-translational modifications might also
suggest that chromatin modification factor/s might tether HIV-1
to specific sites. We have recently demonstrated that cellular
histone-acetyltransferase, p300, acetylates IN and enhances viral
integration [37]. This cellular enzyme, which determines chro-
matin decondensation through histones acetylation, may favor
integration by both acetylating IN and by tethering the virus to
acetylated/decondensed regions of the chromatin. Further study
must be carried out to address these hypotheses [32]. Notably, our
results along with published data might also suggest that in
addition to specific factors, chromatin structure as such might
affect PICs distribution, hence viral integration. One could
speculate that PICs are excluded from the heterochromatin
regions for physical reasons, since this chromatin form is
characterized by pore sizes smaller than 16–20 nm [38] , as
opposed to the 30 nm size of the retroviral PICs [1]. DNA-related
metabolic processes including transcription, recombination, DNA
repair and replication, are coordinated by functionally distinct
chromatin domains spatially arranged within a precisely defined
nuclear architecture [39]. The analysis of HIV-IN-EGFP PICs
immediately revealed a clear preferential position at the nuclear
periphery. Interestingly recent advances highlight the role of
nuclear envelope components in the control of gene expression (for
review, see [40]) thus suggesting that the same nuclear structure
may affect the final site of viral integration.
So far, studies aimed at elucidating integration specificity were
largely based on genomic screening and molecular biology
methods. In this study we have developed and exploited a
fluorescently labeled HIV-1 virus that allowed us to study viral
PICs distribution within intact nuclei by means of advanced
fluorescence microscopy imaging. Important results were previ-
ously obtained in understanding virus-host cell interactions by
tagging viral-particles with fluorophores linked to viral proteins
undetectable at the nuclear levels [21] Only very recently, Arhel et
al have reported the development of a system allowing HIV-1
nuclear visualization [41]. However, the tetracystein-labeling
approach detects only rare PICs within the nucleus and this low
sensitivity, coupled to a fixed analysis time (24 hours in that case,
whereas the time resolved analysis reported in Fig. 6C shows a
clear prevalence of PICs at 6 hours) hampers the possibility to
observe any preferential localization. In the present study the
nuclear localization of PICs was carefully analyzed in infected cells
immunostained with lamin A/C antibodies in order to precisely
define the nuclear compartment. Nuclei were analyzed in a
confocal system at high resolution and imaged in the x-y and x-z
planes. The combination of multidirectional imaging and accurate
image processing allowed us to unambiguously identify the viral
particles located inside the nuclear envelope and distinguish them
from those located in its outer proximity. In fact, infected cells
showed a high number or fluorescent PICs attached to the nuclear
membrane, thus an accurate analysis is strictly necessary to
establish the nuclear nature of viral PICs. Incidentally, the high
frequency of PICs adherent to the borders of the nuclei suggests
that the transition through the nuclear membrane is a strong
limiting factor during viral replication; an observation also
supported by the disproportionate number of nuclear versus
cytoplasmic viral particles (1/50 ratio), as similarly reported by
others [25].
In conclusion, our analysis demonstrated a structured distribu-
tion with respect to the nuclear architecture. We believe that the
relatively early preferential localization in euchromatin regions at
the periphery of the nuclei shown here provides a first indication of
a possible role of the subnuclear structures peculiarities in
addressing the viral genomes towards preferential genome
domains and might offer useful hints for further in depth
investigation of the mechanisms regulating retroviral integration.
Methods
Cells and antibodies
HeLa, 293T and HeLa-H2B-EYFP cells (generously supplied
by Jo ¨rg Langowski) were maintained in DMEM supplemented
with 10% FCS. HeLa-H2B-EYFP cells were cultured in medium
containing 500 mg/ml of G418 (Gibco BRL, Milan, Italy).
Primary antibodies used for immunofluorescence were: mouse
mAb AG3.0 anti-HIV p24
CA and rabbit anti-HIV p17
MA (AIDS
Research and Reference Reagent Program), goat anti-Lamin A/C
(Santa Cruz Biotechnology, Inc., Santa Cruz, CA), rabbit anti-
trimethyl-Histone H3 Lysine 9 (Upstate Biotechnology, NY,
USA). Primary antibodies used for western blot analysis were:
mouse anti-IN 8G4 obtained from the AIDS Research and
Reference Reagent Program and anti-HIV-1 human sera
generously supplied by Maurizio Federico. Secondary antibodies
used for immunofluorescence were: anti-rabbit or anti mouse
conjugated with Alexa-594, Alexa-633 and Alexa-647 (Molecular
Probes, Eugene, OR) and anti-goat conjugated with Alexa-680
(Molecular Probes, Eugene, OR). Secondary antibodies used for
western blot analysis were: anti-mouse and anti-human conjugated
with HRP (Santa Cruz Biotechnology, Inc., Santa Cruz, CA).
Expression plasmids
pVpr-IN-ECFP was constructed by cloning Vpr (PCR amplified
from pNL4.3) in frame with the codon optimized IN [42] into the
pECFP-N1 vector (Clontech Laboratories, Inc., Saint-Germain-
en-Laye, France) In addition an HIV-1 protease cleavage site
(IRKVL), flanked at both C- and N- terminus by a flexible linker
(KRIQST), was introduced between Vpr and IN. pVpr-IN-EGFP
was constructed by substituting the ECFP cDNA with EGFP. The
pD64E and pNL4-3.Luc.R-E- were obtained from the AIDS
Reference and Reagent Program.
Virus Production and Infection
HIV-IN-EGFP (-ECFP) virions were produced by transfecting
3610
6 293T cells by calcium phosphate with 6 mg of pVpr-IN-
EGFP (-ECFP), 6 mg of pD64E and 1 mg of pVSV-G. The control
viruses were produced by transfecting 3610
6 293T cells by
calcium phosphate with 6 mg pNL4-3.Luc.R-E- or pD64E
together with 1 mg pVSV-G. Supernatants were collected after
48 hrs, filtered through a 0.45 mm pore size filter and then
concentrated by ultracentrifugation. For visualization experiments,
luciferase assay and Alu-PCR ultracentrifugation was performed
at 110.0006 g for 2 hrs at 4uC; for western blot analysis at
35,0006g for 1.5 hrs at 4uC on a 20% sucrose cushion. Viral titers
were quantified by RT assay or p24 ELISA (Innogenetics, Gent,
Belgium). Infections for Alu-PCR and luciferase assays were
performed using viral loads equivalent to 157.000 RT cpm on
400.000 cells. For immunofluorescence analysis viral loads
equivalent to 1,5 mgo r3mg of HIV-1-p24 were used to infect
40.000 cells; 2 hrs following infection cells were washed and
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eliminate un-entered virions absorbed onto cellular membrane.
Alu-PCR was performed as described in [37]
Immunofluorescence and NERT fluorescence labeling
Viral particles immunostaining was performed by adsorbing
viral supernatants on chamber slides (BD Biosciences, Bedford,
MA, USA) for 4 hrs at 37uC with 10 mg/ml of polybrene, followed
by rinsing with phosphate-buffered saline (PBS) and fixation with
2% paraformaldehyde in PBS for 15 minutes at room tempera-
ture. Intracellular immunostaining was performed in cells grown
on chamber slides. Coverslips were then fixed with 2%
paraformaldehyde in PBS for 15 minutes at room temperature
followed by incubation for 5 minutes with glycine 100 mM in PBS
and permeabilization with 0,1% Triton X-100 in PBS for
5 minutes. After treatment in blocking buffer (0,1% Tween and
1% BSA in PBS) for 30 minutes, primary antibodies were
incubated for 1 hour at 37uC in blocking buffer followed by
incubation for 1 hr at 37uC with secondary antibodies. Chamber
slides were mounted with Vectashield before microscopy analysis
(Vector Laboratories Inc., Burlingame, CA).
Virions containing fluorescently labeled cDNA by NERT
activity were prepared by incubating 400 ng of p24 viral
supernatants for 4 hrs at 37uC with an endogenous reverse
transcription reaction buffer, as previously described [23,24] and
modified as follows: 10 mM Tris-HCl (pH7.4), 150 mM NaCl,
1 mM MgCl2, 100 mM dATP, 100 mM dCTP, 100 mM dGTP,
25 mM dUTP, 10 mM Alexa-594-dUTP (Molecular Probes,
Eugene, OR).
Image acquisition and analysis
Three-dimensional stacks of fixed cells were acquired with the
TCS SL laser-scanning confocal microscope (Leica Microsystems,
Milan, Italy) equipped with galvanometric stage using a 636/1.4
NA HCX PL APO oil immersion objective. Z-step and y-step size
was 0.3 mm. An Ar laser was used for ECFP (l=458 nm), EGFP
(l=488 nm), EYFP (l=514 nm) and Alexa-680 (l=633 nm)
excitation. Fluorescence emission was collected in the ranges 468–
494, 495–525, 527–585 and 587–722 nm for ECFP, EGFP, EYFP
and Alexa-680, respectively. For the two- and three-color analysis
a sequential image acquisition was used to reduce crosstalk
between different signals below 5%. Multi-channel images were
contrast stretched (linearly) and assembled in ImageJ (NIH). H2B-
EYFP fluorescence intensity among different cell images were
normalized using the following procedure: for the acquisition the
laser power was adjusted to maximize dynamic range and to avoid
image saturation with the brightest value ranging between 220 and
250; the contrast range was then linearly expanded assigning the
brightest value to 255. For cross analysis with 3MeK9H3 staining
the H2B-EYFP fluorescence intensity was quantified in the
3MeK9H3 positive regions after rescaling with the above-
described procedure.
Raw data (i.e. confocal z stacks) were deconvolved using the
experimental PSF measured for each channel and imposing the
optical parameters adopted during image acquisition. For each
fluorescent channel the point spread function (PSF) of the
microscope was calculated using PSF distilled function in Huygens
Essential software (Scientific Volume Imaging BV. Hilversum,
The Netherlands). There the lamin A/C Alexa-680 signal (blue)
was linearly expanded between 30 and 250, while the PICs signal
(green) between 2 and 50. The applied lookup table defines a grey
background for values below the cutoff=30.
Supporting Information
Figure S1 Vertical y stack series of nuclear HIV-IN-EGFP PICs.
Vertical y stack of a HeLa cell nucleus infected with IN-EGFP
virions (green) and immunostained with lamin A/C antibody
(blue). A distance of 0.3 mm separates adjacent frames. White
arrows indicate a single viral PIC identified as intranuclear and
visible in two subsequent sections. Bars, 5 mm.
Found at: doi:10.1371/journal.pone.0002413.s001 (11.60 MB
DOC)
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